Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure

Juno Therapeutics, Inc. (JUNO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2019 SC 13G/A Capital International Investors reports a 0% stake in Juno Therapeutics Inc.
04/16/2018 CT ORDER Form CT ORDER - Confidential treatment order:
03/16/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
03/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/07/2018 4 Wilderotter Mary Agnes (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 75,000 options to buy @ $8.72, valued at $654k
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 PIEN HOWARD H (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Gifted 12,251 shares @ $0
Gifted 1,162 shares @ $0
Unknown transaction of 111,587 shares @ $87, valued at $9.7M
Disposed/sold 5,050 shares @ $87, valued at $439.4k
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 NELSEN ROBERT (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 50,824 shares @ $87, valued at $4.4M
Disposed/sold 3,234 shares @ $87, valued at $281.4k
Unknown transaction of 10,552,390 shares @ $87, valued at $918.1M
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 LEE ANN L. (EVP, Technical Operations) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 35,004 shares @ $0
Disposed/sold 40,788 shares @ $0
Disposed/sold 35,000 shares @ $0
Disposed/sold 152,900 options to buy @ $62.85, valued at $9.6M
03/07/2018 4 Klausner Richard (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Gifted 23,250 shares @ $0
Unknown transaction of 705,525 shares @ $87, valued at $61.4M
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 492,355 shares @ $87, valued at $42.8M
Disposed/sold 50,010 shares @ $87, valued at $4.4M
Disposed/sold 20,580 shares @ $0
Disposed/sold 29,135 shares @ $0
Disposed/sold 11,544 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 98,750 options to buy @ $8.72, valued at $861.1k
Disposed/sold 85,000 options to buy @ $48.06, valued at $4.1M
Disposed/sold 155,000 options to buy @ $24.5, valued at $3.8M
Disposed/sold 127,841 options to buy @ $20.76, valued at $2.7M
03/07/2018 4 FLATLEY JAY T (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 31,500 shares @ $87, valued at $2.7M
Disposed/sold 18,000 options to buy @ $24.07, valued at $433.3k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 EVNIN ANTHONY B (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Gifted 25,000 shares @ $0
Gifted 34,842 shares @ $0
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Daniel Thomas O (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Cassidy Bernard J (General Counsel & Secretary) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 5,558 shares @ $87, valued at $483.5k
Disposed/sold 18,293 shares @ $0
Disposed/sold 25,639 shares @ $0
Disposed/sold 35,893 shares @ $0
Unknown transaction of 26,869 shares @ $87, valued at $2.3M
Disposed/sold 125,000 options to buy @ $6.36, valued at $795k
Disposed/sold 37,500 options to buy @ $8.72, valued at $327k
Disposed/sold 50,500 options to buy @ $48.06, valued at $2.4M
Disposed/sold 75,000 options to buy @ $24.5, valued at $1.8M
Disposed/sold 113,636 options to buy @ $20.76, valued at $2.4M
03/07/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 2,263,948 shares @ $87, valued at $197M
Disposed/sold 48,829 shares @ $87, valued at $4.2M
Disposed/sold 33,133 shares @ $0
Disposed/sold 66,426 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 451,756 options to buy @ $6.36, valued at $2.9M
Disposed/sold 140,000 options to buy @ $48.06, valued at $6.7M
Disposed/sold 200,000 options to buy @ $24.5, valued at $4.9M
Disposed/sold 205,823 options to buy @ $20.76, valued at $4.3M
03/07/2018 4 Barron Hal (Director) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 100,000 shares @ $87, valued at $8.7M
Disposed/sold 3,780 shares @ $87, valued at $328.9k
Disposed/sold 75,000 options to buy @ $6.36, valued at $477k
Disposed/sold 12,000 options to buy @ $60, valued at $720k
Disposed/sold 12,000 options to buy @ $42.4, valued at $508.8k
Disposed/sold 12,000 options to buy @ $23.29, valued at $279.5k
03/07/2018 4 Azelby Robert (EVP & Chief Commercial Officer) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 7,500 shares @ $0
Disposed/sold 20,580 shares @ $0
Disposed/sold 25,639 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 93,294 options to buy @ $51.76, valued at $4.8M
Disposed/sold 30,002 options to buy @ $25.29, valued at $758.8k
Disposed/sold 98,545 options to buy @ $20.76, valued at $2M
03/07/2018 4 AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Disposed/sold 84,549 shares @ $0
Disposed/sold 29,135 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 313,797 options to buy @ $24.01, valued at $7.5M
03/06/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/06/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/06/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/06/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/06/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/06/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
03/06/2018 3 CELGENE CORP /DE/ (10% Owner) has filed a Form 3 on Juno Therapeutics, Inc.
03/05/2018 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
03/05/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/05/2018 SC 13D/A CELGENE CORP reports a 85.4% stake in JUNO THERAPEUTICS, INC.
03/05/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/01/2018 4 Harr Steve (CFO & Head, Corp. Development) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 11,544 shares @ $0
03/01/2018 10-K Annual Report for the period ended December 31, 2017
02/22/2018 SC 13D/A CELGENE CORP reports a 9.7% stake in JUNO THERAPEUTICS, INC.
02/22/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy